CYP7A1 and type 2 diabetes mellitus: A study has also indicated that increased expression of FXR and FGF15 in the intestine, along with decreased expression of CYP7A1 in the liver, contributed to treating T2DM in rats (Tawulie et al., 2023), which was consistent with the findings of this research.